Venture capital is the lifeblood of up-and-coming biotechs. In order to interest investors and keep the money coming in, biotechs must have a strong vision, promising pipeline and a management team that can guide a company through the rigorous drug development process. For a look at which biotechs have gained the most attention this year, check out the five promising companies that raised the most money in the first half of 2007.
 Portola Pharmaceuticals [3]
Novexel [4]
Movetis [5]
Links:
[1] http://www.fiercebiotech.com/special-reports/ception-therapeutics
[2] http://www.fiercebiotech.com/special-reports/targanta-therapeutics
[3] http://www.fiercebiotech.com/special-reports/portola-pharmaceuticals
[4] http://www.fiercebiotech.com/special-reports/novexel
[5] http://www.fiercebiotech.com/special-reports/movetis